These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 12124422

  • 1. Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways.
    Iacovelli L, Bruno V, Salvatore L, Melchiorri D, Gradini R, Caricasole A, Barletta E, De Blasi A, Nicoletti F.
    J Neurochem; 2002 Jul; 82(2):216-23. PubMed ID: 12124422
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways.
    D'Onofrio M, Cuomo L, Battaglia G, Ngomba RT, Storto M, Kingston AE, Orzi F, De Blasi A, Di Iorio P, Nicoletti F, Bruno V.
    J Neurochem; 2001 Aug; 78(3):435-45. PubMed ID: 11483646
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/akt-dependent and MAPK/CREB-independent.
    Hossain MA, Russell JC, Gomez R, Laterra J.
    J Neurochem; 2002 Apr; 81(2):365-78. PubMed ID: 12064484
    [Abstract] [Full Text] [Related]

  • 4. Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways.
    Subramaniam S, Strelau J, Unsicker K.
    J Biol Chem; 2003 Mar 14; 278(11):8904-12. PubMed ID: 12514175
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of non-vesicular glutamate release by group III metabotropic glutamate receptors in the nucleus accumbens.
    Xi ZX, Shen H, Baker DA, Kalivas PW.
    J Neurochem; 2003 Dec 14; 87(5):1204-12. PubMed ID: 14622100
    [Abstract] [Full Text] [Related]

  • 6. Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina.
    Manabe S, Lipton SA.
    Invest Ophthalmol Vis Sci; 2003 Jan 14; 44(1):385-92. PubMed ID: 12506100
    [Abstract] [Full Text] [Related]

  • 7. Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones.
    Perkinton MS, Ip JK, Wood GL, Crossthwaite AJ, Williams RJ.
    J Neurochem; 2002 Jan 14; 80(2):239-54. PubMed ID: 11902114
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression.
    Wu X, Zhu D, Jiang X, Okagaki P, Mearow K, Zhu G, McCall S, Banaudha K, Lipsky RH, Marini AM.
    J Neurochem; 2004 Aug 14; 90(4):807-18. PubMed ID: 15287886
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
    Zhu Y, Culmsee C, Klumpp S, Krieglstein J.
    Neuroscience; 2004 Aug 14; 123(4):897-906. PubMed ID: 14751283
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
    Squires MS, Hudson EA, Howells L, Sale S, Houghton CE, Jones JL, Fox LH, Dickens M, Prigent SA, Manson MM.
    Biochem Pharmacol; 2003 Feb 01; 65(3):361-76. PubMed ID: 12527329
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O, Cantley LC.
    Exp Cell Res; 2004 Jul 01; 297(1):224-34. PubMed ID: 15194438
    [Abstract] [Full Text] [Related]

  • 16. Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease.
    Austin PJ, Betts MJ, Broadstock M, O'Neill MJ, Mitchell SN, Duty S.
    Br J Pharmacol; 2010 Aug 01; 160(7):1741-53. PubMed ID: 20649576
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways.
    Xia Y, Wang CZ, Liu J, Anastasio NC, Johnson KM.
    Neuropharmacology; 2010 Feb 01; 58(2):330-6. PubMed ID: 19887077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.